HEATHER CYPHER: Open Payments
NPI 1033835772 · HAMILTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,765 in 154 payments from 17 companies in 2025. Trend: 2023 $2,974 · 2024 $1,391 · 2025 $2,765
Food & beverage: $2,765
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $660 |
| ABBVIE INC. | 36 | $386 |
| Vanda Pharmaceuticals Inc. | 18 | $289 |
| Teva Pharmaceuticals USA, Inc. | 8 | $260 |
| Otsuka America Pharmaceutical, Inc. | 21 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $191 |
| Janssen Pharmaceuticals, Inc | 12 | $174 |
| Lundbeck LLC | 9 | $146 |
| Supernus Pharmaceuticals, Inc. | 6 | $101 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
Products named: Auvelity, VRAYLAR, REXULTI, AUSTEDO XR, CAPLYTA, SPRAVATO, HETLIOZ, FANAPT.
Industry payments across OH — which companies pay providers there.
